Works by Juric, Dejan


Results: 32
    1

    Small cell transformation of ROS1 fusion-positive lung cancer resistant to ROS1 inhibition.

    Published in:
    2020
    By:
    • Lin, Jessica J.;
    • Langenbucher, Adam;
    • Gupta, Pranav;
    • Yoda, Satoshi;
    • Fetter, Isobel J.;
    • Rooney, Marguerite;
    • Do, Andrew;
    • Kem, Marina;
    • Chang, Kylie Prutisto;
    • Oh, Audris Y.;
    • Chin, Emily;
    • Juric, Dejan;
    • Corcoran, Ryan B.;
    • Dagogo-Jack, Ibiayi;
    • Gainor, Justin F.;
    • Stone, James R.;
    • Lennerz, Jochen K.;
    • Lawrence, Michael S.;
    • Hata, Aaron N.;
    • Mino-Kenudson, Mari
    Publication type:
    Case Study
    2

    Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer.

    Published in:
    Science Signaling, 2014, v. 7, n. 318, p. 1, doi. 10.1126/scisignal.2005125
    By:
    • Tao, Jessica J.;
    • Castel, Pau;
    • Radosevic-Robin, Nina;
    • Elkabets, Moshe;
    • Auricchio, Neil;
    • Aceto, Nicola;
    • Weitsman, Gregory;
    • Barber, Paul;
    • Vojnovic, Borivoj;
    • Ellis, Haley;
    • Morse, Natasha;
    • Viola-Villegas, Nerissa Therese;
    • Bosch, Ana;
    • Juric, Dejan;
    • Hazra, Saswati;
    • Singh, Sharat;
    • Kim, Phillip;
    • Bergamaschi, Anna;
    • Maheswaran, Shyamala;
    • Ng, Tony
    Publication type:
    Article
    3
    4

    Cell Atlas of The Human Fovea and Peripheral Retina.

    Published in:
    Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-66092-9
    By:
    • Yan, Wenjun;
    • Peng, Yi-Rong;
    • van Zyl, Tavé;
    • Regev, Aviv;
    • Shekhar, Karthik;
    • Juric, Dejan;
    • Sanes, Joshua R.
    Publication type:
    Article
    5
    6
    7
    8

    Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221119370
    By:
    • Denault, Elyssa;
    • Nakajima, Erika;
    • Naranbhai, Vivek;
    • Hutchinson, Jennifer A.;
    • Mortensen, Lindsey;
    • Neihoff, Elizabeth;
    • Barabell, Caroline;
    • Comander, Amy;
    • Juric, Dejan;
    • Kuter, Irene;
    • Mulvey, Theresa;
    • Peppercorn, Jeffrey;
    • Rosenstock, Aron S.;
    • Shin, Jennifer;
    • Vidula, Neelima;
    • Wander, Seth A.;
    • Moy, Beverly;
    • Ellisen, Leif W.;
    • Isakoff, Steven J.;
    • Iafrate, A. John
    Publication type:
    Article
    9

    Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer.

    Published in:
    Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01132-z
    By:
    • Tsimberidou, Apostolia-Maria;
    • Shaw, Jamie V.;
    • Juric, Dejan;
    • Verschraegen, Claire;
    • Weise, Amy M.;
    • Sarantopoulos, John;
    • Lopes, Gilberto;
    • Nemunaitis, John;
    • Mita, Monica;
    • Park, Haeseong;
    • Ellers-Lenz, Barbara;
    • Tian, Hui;
    • Xiong, Wenyuan;
    • Kaleta, Remigiusz;
    • Kurzrock, Razelle
    Publication type:
    Article
    10

    Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer.

    Published in:
    NPJ Precision Oncology, 2019, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41698-019-0090-5
    By:
    • Medford, Arielle J.;
    • Dubash, Taronish D.;
    • Juric, Dejan;
    • Spring, Laura;
    • Niemierko, Andrzej;
    • Vidula, Neelima;
    • Peppercorn, Jeffrey;
    • Isakoff, Steven;
    • Reeves, Brittany A.;
    • LiCausi, Joseph A.;
    • Wesley, Benjamin;
    • Malvarosa, Giuliana;
    • Yuen, Megan;
    • Wittner, Ben S.;
    • Lawrence, Michael S.;
    • Iafrate, A. John;
    • Ellisen, Leif;
    • Moy, Beverly;
    • Toner, Mehmet;
    • Maheswaran, Shyamala
    Publication type:
    Article
    11
    12
    13

    Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor.

    Published in:
    Nature, 2015, v. 518, n. 7538, p. 240, doi. 10.1038/nature13948
    By:
    • Juric, Dejan;
    • Castel, Pau;
    • Griffith, Malachi;
    • Griffith, Obi L.;
    • Won, Helen H.;
    • Ellis, Haley;
    • Ebbesen, Saya H.;
    • Ainscough, Benjamin J.;
    • Ramu, Avinash;
    • Iyer, Gopa;
    • Shah, Ronak H.;
    • Huynh, Tiffany;
    • Mino-Kenudson, Mari;
    • Sgroi, Dennis;
    • Isakoff, Steven;
    • Thabet, Ashraf;
    • Elamine, Leila;
    • Solit, David B.;
    • Lowe, Scott W.;
    • Quadt, Cornelia
    Publication type:
    Article
    14
    15
    16
    17

    mTORC1 Inhibition Is Required for Sensitivity to PI3K p110α Inhibitors in PIK3CA-Mutant Breast Cancer.

    Published in:
    Science Translational Medicine, 2013, v. 5, n. 196, p. 1, doi. 10.1126/scitranslmed.3005747
    By:
    • Elkabets, Moshe;
    • Vora, Sadhna;
    • Juric, Dejan;
    • Morse, Natasha;
    • Mino-Kenudson, Mari;
    • Muranen, Taru;
    • Tao, Jessica;
    • Campos, Ana Bosch;
    • Rodon, Jordi;
    • Ibrahim, Yasir H.;
    • Serra, Violeta;
    • Rodrik-Outmezguine, Vanessa;
    • Hazra, Saswati;
    • Singh, Sharat;
    • Kim, Phillip;
    • Quadt, Cornelia;
    • Manway Liu;
    • Huang, Alan;
    • Rosen, Neal;
    • Engelman, Jeffrey A.
    Publication type:
    Article
    18
    19

    Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique.

    Published in:
    NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00613-x
    By:
    • Gallagher, Emily J.;
    • Moore, Heather;
    • Lacouture, Mario E.;
    • Dent, Susan F.;
    • Farooki, Azeez;
    • Goncalves, Marcus D.;
    • Isaacs, Claudine;
    • Johnston, Abigail;
    • Juric, Dejan;
    • Quandt, Zoe;
    • Spring, Laura;
    • Berman, Brian;
    • Decker, Melanie;
    • Hortobagyi, Gabriel N.;
    • Kaffenberger, Benjamin H.;
    • Kwong, Bernice Y.;
    • Pluard, Timothy;
    • Rao, Ruta;
    • Schwartzberg, Lee;
    • Broder, Michael S.
    Publication type:
    Article
    20

    A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors.

    Published in:
    Cancer Medicine, 2024, v. 13, n. 5, p. 1, doi. 10.1002/cam4.6776
    By:
    • Juric, Dejan;
    • Barve, Minal;
    • Vaishampayan, Ulka;
    • Roda, Desamparados;
    • Calvo, Aitana;
    • Jañez, Noelia Martinez;
    • Trigo, Jose;
    • Greystoke, Alastair;
    • Harvey, R. Donald;
    • Olszanski, Anthony J.;
    • Opyrchal, Mateusz;
    • Spira, Alexander;
    • Thistlethwaite, Fiona;
    • Jiménez, Begoña;
    • Sappal, Jessica Huck;
    • Kannan, Karuppiah;
    • Riley, Jason;
    • Li, Cheryl;
    • Li, Cong;
    • Gregory, Richard C.
    Publication type:
    Article
    21

    Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection.

    Published in:
    Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-20139-7
    By:
    • Desai, Niyati;
    • Neyaz, Azfar;
    • Szabolcs, Annamaria;
    • Shih, Angela R.;
    • Chen, Jonathan H.;
    • Thapar, Vishal;
    • Nieman, Linda T.;
    • Solovyov, Alexander;
    • Mehta, Arnav;
    • Lieb, David J.;
    • Kulkarni, Anupriya S.;
    • Jaicks, Christopher;
    • Xu, Katherine H.;
    • Raabe, Michael J.;
    • Pinto, Christopher J.;
    • Juric, Dejan;
    • Chebib, Ivan;
    • Colvin, Robert B.;
    • Kim, Arthur Y.;
    • Monroe, Robert
    Publication type:
    Article
    22

    A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer.

    Published in:
    2017
    By:
    • Reynolds, Kerry Lynn;
    • Bedard, Philippe L.;
    • Se-Hoon Lee;
    • Chia-Chi Lin;
    • Tabernero, Josep;
    • Alsina, Maria;
    • Cohen, Ezra;
    • Baselga, José;
    • Blumenschein Jr., George;
    • Graham, Donna M.;
    • Garrido-Laguna, Ignacio;
    • Juric, Dejan;
    • Sharma, Sunil;
    • Salgia, Ravi;
    • Seroutou, Abdelkader;
    • Xianbin Tian;
    • Fernandez, Rose;
    • Morozov, Alex;
    • Qing Sheng;
    • Ramkumar, Thiruvamoor
    Publication type:
    journal article
    23
    24
    25
    26

    Financial toxicity in early‐phase cancer clinical trial participants.

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 1, p. 1, doi. 10.1002/cncr.35586
    By:
    • Durbin, Sienna M.;
    • Lundquist, Debra;
    • Pelletier, Andrea;
    • Petrillo, Laura A.;
    • Bame, Viola;
    • Turbini, Victoria;
    • Heldreth, Hope;
    • Lynch, Kaitlyn;
    • Boulanger, Mary;
    • Lam, Anh;
    • McIntyre, Casandra;
    • Ferrell, Betty R.;
    • Jimenez, Rachel;
    • Juric, Dejan;
    • Nipp, Ryan D.
    Publication type:
    Article
    27

    A phase 1 study evaluating safety and pharmacokinetics of losatuxizumab vedotin (ABBV-221), an anti-EGFR antibody-drug conjugate carrying monomethyl auristatin E, in patients with solid tumors likely to overexpress EGFR.

    Published in:
    Investigational New Drugs, 2020, v. 38, n. 5, p. 1483, doi. 10.1007/s10637-020-00908-3
    By:
    • Cleary, James M.;
    • Calvo, Emiliano;
    • Moreno, Victor;
    • Juric, Dejan;
    • Shapiro, Geoffrey I.;
    • Vanderwal, Carol Ann;
    • Hu, Beibei;
    • Gifford, Maryella;
    • Barch, David;
    • Roberts-Rapp, Lisa;
    • Ansell, Peter J.;
    • Xiong, Hao;
    • Ocampo, Christopher;
    • Tolcher, Anthony W.
    Publication type:
    Article
    28
    29
    30
    31

    Overall Survival of CDK4/6-Inhibitor-Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-Analysis.

    Published in:
    2020
    By:
    • Schettini, Francesco;
    • Giudici, Fabiola;
    • Giuliano, Mario;
    • Cristofanilli, Massimo;
    • Arpino, Grazia;
    • Mastro, Lucia Del;
    • Puglisi, Fabio;
    • Placido, Sabino De;
    • Paris, Ida;
    • Placido, Pietro De;
    • Venturini, Sergio;
    • Laurentis, Michelino De;
    • Conte, PierFranco;
    • Juric, Dejan;
    • Llombart-Cussac, Antonio;
    • Pusztai, Lajos;
    • Prat, Aleix;
    • Jerusalem, Guy;
    • Leo, Angelo Di;
    • Generali, Daniele
    Publication type:
    journal article
    32

    Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25859-y
    By:
    • Brastianos, Priscilla K.;
    • Strickland, Matthew R.;
    • Lee, Eudocia Quant;
    • Wang, Nancy;
    • Cohen, Justine V.;
    • Chukwueke, Ugonma;
    • Forst, Deborah Anne;
    • Eichler, April;
    • Overmoyer, Beth;
    • Lin, Nancy U.;
    • Chen, Wendy Y.;
    • Bardia, Aditya;
    • Juric, Dejan;
    • Dagogo-Jack, Ibiayi;
    • White, Michael D.;
    • Dietrich, Jorg;
    • Nayyar, Naema;
    • Kim, Albert E.;
    • Alvarez-Breckenridge, Christopher;
    • Mahar, Maura
    Publication type:
    Article